Central nervous system (CNS) diseases have become a major global public health challenge. With the extension of human lifespan and the intensification of population aging, the incidence of these diseases has shown a significant upward trend, yet their clinical treatment still faces critical technological bottlenecks. The presence of the blood-brain barrier (BBB) hinders the delivery of over 98% of small-molecule drugs and nearly all macromolecular drugs into the brain, rendering conventional drug administration methods unable to achieve effective therapeutic concentrations. In recent years, brain-targeted nano-drug delivery systems based on nanotechnology have demonstrated breakthrough potential: nanocarriers can improve the efficiency of drug crossing the BBB through size effects; surface functional modifications enable precise drug delivery to the brain. This article describes the composition and function of the BBB, the types of nanocarriers, and brain-targeting strategies via functional group modifications, aiming to provide theoretical foundations and technical references for developing safe and efficient brain-targeted nano-drug delivery systems.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |